Literature DB >> 24408889

Large simple trials: really, it can't be that simple!

Robert M Califf1.   

Abstract

Mesh：

Year:  2014        PMID： 24408889      PMCID： PMC3988455          DOI： 10.1093/eurheartj/eht556

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  6 in total

1.  Thrombus aspiration during ST-segment elevation myocardial infarction.

Authors:  Ole Fröbert; Bo Lagerqvist; Göran K Olivecrona; Elmir Omerovic; Thorarinn Gudnason; Michael Maeng; Mikael Aasa; Oskar Angerås; Fredrik Calais; Mikael Danielewicz; David Erlinge; Lars Hellsten; Ulf Jensen; Agneta C Johansson; Amra Kåregren; Johan Nilsson; Lotta Robertson; Lennart Sandhall; Iwar Sjögren; Ollie Ostlund; Jan Harnek; Stefan K James
Journal:  N Engl J Med       Date:  2013-08-31       Impact factor: 91.245

2.  Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010.

Authors:  Robert M Califf; Deborah A Zarin; Judith M Kramer; Rachel E Sherman; Laura H Aberle; Asba Tasneem
Journal:  JAMA       Date:  2012-05-02       Impact factor: 56.272

3.  Biomarker-guided therapies in heart failure: a forum for unified strategies.

Authors:  Mona Fiuzat; Christopher M O'Connor; Francois Gueyffier; Alice M Mascette; Nancy L Geller; Alexandre Mebazaa; Adriaan A Voors; Kirkwood F Adams; Ileana L Piña; Ludwig Neyses; Pieter Muntendam; G Michael Felker; Bertram Pitt; Faiez Zannad; Michael R Bristow
Journal:  J Card Fail       Date:  2013-08       Impact factor: 5.712

4.  Embedding a randomized clinical trial into an ongoing registry infrastructure: unique opportunities for efficiency in design of the Study of Access site For Enhancement of Percutaneous Coronary Intervention for Women (SAFE-PCI for Women).

Authors:  Connie N Hess; Sunil V Rao; David F Kong; Laura H Aberle; Kevin J Anstrom; C Michael Gibson; Ian C Gilchrist; Alice K Jacobs; Sanjit S Jolly; Roxana Mehran; John C Messenger; L Kristin Newby; Ron Waksman; Mitchell W Krucoff
Journal:  Am Heart J       Date:  2013-07-23       Impact factor: 4.749

5.  Why do we need some large, simple randomized trials?

Authors:  S Yusuf; R Collins; R Peto
Journal:  Stat Med       Date:  1984 Oct-Dec       Impact factor: 2.373

6.  Therapeutic potential of aleglitazar, a new dual PPAR-α/γ agonist: implications for cardiovascular disease in patients with diabetes mellitus.

Authors:  Matthew A Cavender; A Michael Lincoff
Journal:  Am J Cardiovasc Drugs       Date:  2010       Impact factor: 3.571
  6 in total
  2 in total

1.  Benefit of dual-chamber pacing with Closed Loop Stimulation in tilt-induced cardio-inhibitory reflex syncope (BIOSync trial): study protocol for a randomized controlled trial.

Authors:  Michele Brignole; Marco Tomaino; Arnaud Aerts; Fabrizio Ammirati; Félix Alejandro Ayala-Paredes; Jean-Claude Deharo; Attilio Del Rosso; Mohamed H Hamdan; Maurizio Lunati; Angel Moya; Alessio Gargaro
Journal:  Trials       Date:  2017-05-04       Impact factor: 2.279

2.  Design and rationale of a multi-center, pragmatic, open-label randomized trial of antimicrobial therapy - the study of clinical efficacy of antimicrobial therapy strategy using pragmatic design in Idiopathic Pulmonary Fibrosis (CleanUP-IPF) clinical trial.

Authors:  Kevin J Anstrom; Imre Noth; Kevin R Flaherty; Rex H Edwards; Joan Albright; Amanda Baucom; Maria Brooks; Allan B Clark; Emily S Clausen; Michael T Durheim; Dong-Yun Kim; Jerry Kirchner; Justin M Oldham; Laurie D Snyder; Andrew M Wilson; Stephen R Wisniewski; Eric Yow; Fernando J Martinez
Journal:  Respir Res       Date:  2020-03-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.